当前位置:
X-MOL 学术
›
Blood Cancer J.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Venetoclax with hypomethylating agents versus intensive chemotherapy in newly diagnosed acute myeloid leukemia with myelodysplasia related changes: A propensity score-matched analysis based on International Consensus Classification
Blood Cancer Journal ( IF 12.9 ) Pub Date : 2024-08-23 , DOI: 10.1038/s41408-024-01130-7 Chao-Ling Wan 1, 2 , Yu-Qing Liu 3 , Fang-Tong Liu 1, 2 , Yuan-Hong Huang 1, 2 , Han-Yu Cao 1, 2 , Si-Man Huang 1, 2 , Kai-Wen Tan 1, 2 , Shuai-Shuai Ge 1, 2 , Miao Wang 1, 2 , Mei-Jing Liu 1, 2 , Zi-Hao Wang 1, 2 , Zheng Li 1, 2 , Sheng-Li Xue 1, 2 , Hai-Ping Dai 1, 2
中文翻译:
维奈托克联合低甲基化药物与强化化疗治疗新诊断的急性髓系白血病伴骨髓增生异常相关变化:基于国际共识分类的倾向评分匹配分析
更新日期:2024-08-23
Blood Cancer Journal ( IF 12.9 ) Pub Date : 2024-08-23 , DOI: 10.1038/s41408-024-01130-7 Chao-Ling Wan 1, 2 , Yu-Qing Liu 3 , Fang-Tong Liu 1, 2 , Yuan-Hong Huang 1, 2 , Han-Yu Cao 1, 2 , Si-Man Huang 1, 2 , Kai-Wen Tan 1, 2 , Shuai-Shuai Ge 1, 2 , Miao Wang 1, 2 , Mei-Jing Liu 1, 2 , Zi-Hao Wang 1, 2 , Zheng Li 1, 2 , Sheng-Li Xue 1, 2 , Hai-Ping Dai 1, 2
Affiliation
中文翻译:
维奈托克联合低甲基化药物与强化化疗治疗新诊断的急性髓系白血病伴骨髓增生异常相关变化:基于国际共识分类的倾向评分匹配分析